Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | CASP1 | P29466 | 2/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.46 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29361503 | 1.00 | HTT (1.00) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| Benzoquinone SCHEMBL28253111 | 0.89 | CYP1A2 (0.79) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL358850 | 0.83 | HTT (0.70) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL29448230 | 0.83 | HTT (0.70) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28206946 | 0.82 | HTT (0.68) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| Water SCHEMBL28126820 | 0.81 | HTT (0.68) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL20292903 | 0.81 | HTT (0.68) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL29485612 | 0.77 | NPC1 (0.68) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL3726615 | 0.77 | NPC1 (0.68) | HTTCYP1A2CYP2C19ALDH1A1MEN1 | |
| SCHEMBL22117518 | 0.76 | CYP3A4 (0.63) | HTTCYP1A2CYP2C19ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798539-B | Organic super-fluorescent scintillator without heavy atom modification and preparation method and application thereof | 南京邮电大学 | 2025-06-10 | — | — | CN | claimed |
| CN-119798539-A | Organic super-fluorescent scintillator without heavy atom modification and preparation method and application thereof | 南京邮电大学 | 2025-04-11 | — | — | CN | claimed |
| CN-110229102-B | 2-alkylated quinoline, derivative and synthetic method thereof | 湘潭大学 | 2022-05-17 | — | — | CN | claimed |
| US-11242957-B2 | Kinetic hydrate inhibitors for controlling gas hydrate formation in wet gas systems | CHAMPIONX USA INC. (US) | 2022-02-08 | — | — | US | claimed |
| US-20190353307-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | HARBISON-FISCHER, INC. | 2019-11-21 | — | — | US | claimed |
| CN-110229102-A | 2- is alkylated quinoline, derivative and its synthetic method | 湘潭大学 | 2019-09-13 | — | — | CN | claimed |
| EP-3420055-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | Ecolab USA Inc. (US) | 2019-01-02 | — | — | EP | claimed |
| WO-2017147426-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | ECOLAB USA INC. (US) | 2017-08-31 | — | — | WO | claimed |
| US-20170248276-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | US SYNTHETIC CORPORATION | 2017-08-31 | — | — | US | claimed |
| US-12435128-B2 | Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1 | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2025-10-07 | — | — | US | disclosed |
| EP-4010330-B1 | QUINOLINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | HIRUNDO BIOSCIENCES (BE) | 2025-10-01 | — | — | EP | disclosed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
| EP-4598923-A1 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | The Regents of the University of California (US) | 2025-08-13 | — | — | EP | disclosed |
| US-12371454-B2 | Cyclic peptide compound having Kras inhibitory action | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-0363212-B1 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-5204348-A | Quinoline derivatives | MITSUI TOATSU CHEMICALS INC. (JP) | 1993-04-20 | — | — | US | disclosed |
| EP-0533344-A1 | Methanoanthracenes as dopamine antagonists | ZENECA LIMITED (GB) | 1993-03-24 | — | — | EP | disclosed |
| US-5141931-A | 5-Quinolinylpyridinones, cardiotonic compositions and methods | STERLING WINTHROP INC. (US) | 1992-08-25 | — | — | US | disclosed |
| US-5112817-A | Anticancer Drug Potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0363212-A2 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | HTT 1767/4885CYP1A2 4816/4885CYP2C19 4727/4885 |
| US-12435128-B2 | Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1 | INMT, CARM1, KDM1B | HTT 4089/4885CYP1A2 1947/4885CYP2C19 3289/4885 |
| US-12371454-B2 | Cyclic peptide compound having Kras inhibitory action | KRAS, NRAS, HRAS | HTT 3175/4885CYP1A2 4845/4885CYP2C19 4509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.